Bibliographic survey on the clinical application of magnetoencephalography (IV): Psychiatric diseases and dementia
-
- Ishii Ryouhei
- Department of Psychiatry, Osaka University Graduate School of Medicine
-
- Watanabe Yutaka
- National Center Hospital, National Center of Neurology and Psychiatry
-
- Aoki Yasunori
- Department of Psychiatry, Osaka University Graduate School of Medicine
-
- Hirata Masayuki
- Department of Neurosurgery, Osaka University Graduate School of Medicine
-
- Shiraishi Hideaki
- Department of Pediatrics, Hokkaido University Graduate School of Medicine
-
- Ozaki Isamu
- Faculty of Health Sciences, Aomori University of Health and Welfare
-
- Iguchi Yoshinobu
- Integrated Neuroscience Research Project, Tokyo Metropolitan Institute of Medical Science
-
- Tsuyuguchi Naohiro
- Department of Neurosurgery, Osaka City University Graduate School of Medicine
-
- Kamada Kyousuke
- Department of Neurosurgery, Asahikawa Medical University
-
- Kameyama Shigeki
- Nishi-Niigata Chuo National Hospital
-
- Nakasato Nobukazu
- Department of Epileptology, Tohoku University
-
- Hashimoto Isao
- Kanazawa Institutes of Technology
-
- Takeda Masatoshi
- Department of Psychiatry, Osaka University Graduate School of Medicine
Bibliographic Information
- Other Title
-
- 脳磁図の臨床応用に関する文献レビュー (第4報) : 精神科疾患・認知症
- ノウジズ ノ リンショウ オウヨウ ニ カンスル ブンケン レビュー(ダイ4ホウ)セイシンカ シッカン ・ ニンチショウ
Search this article
Abstract
Magnetoencephalography (MEG) is a powerful tool of basic and clinical neuroscience to detect real neuronal activities directly and non-invasively with good time and spatial resolution. Since the ministry of health in Japan approved MEG as clinical examination covered by health insurance in 2004, many patients suffering from various brain disorders benefitted from this method for these years. We reviewed clinical MEG studies regarding psychiatry diseases and dementia based on a website bibliographic survey before March 2012 on MEDLINE using the keywords of each disease AND (MEG OR magnetoencephalography). We found 95 papers about schizophrenia, 23 about mood disorders, 29 about developmental disorders, 13 about epilepsy psychosis, 71 about dementia. Then, we selected several papers with evidence level higher than 3 to assess the clinical utility of MEG. Although a few studies stressed the superiority of MEG compared to EEG for the diagnosis or treatment indication for psychiatric diseases and dementia, we could not find any papers with evidence level higher than 2 except two about dementia. Future development is needed for more objective analysis of MEG findings in psychiatry diseases and dementia.
Journal
-
- Japanese Journal of Clinical Neurophysiology
-
Japanese Journal of Clinical Neurophysiology 41 (1), 29-45, 2013
Japanese Society of Clinical Neurophysiology
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205511324672
-
- NII Article ID
- 130005003304
-
- NII Book ID
- AA11410258
-
- ISSN
- 2188031X
- 13457101
-
- NDL BIB ID
- 030738312
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed